Reduction of ITGB1 by siRNA treatment led to 20–60% reduction in the adhesion capability (Figure 6C,D), and 60–70% reduction in the migration capability of NPC cells (Figure 6E,F). Here, ITGB1 is linked to nasopharyngeal carcinoma.